Primary Site >> Biliary tract Cancer
Gene >> TIMP2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Expression of MMP-2,TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance. PMID: 12439941 |
Ref: Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma. PMID: 14687144 Ref: [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism]. PMID: 15312360 Ref: The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study. PMID: 15567754 Ref: Immunohistochemical study of characteristics of bile duct dysplasia evaluated on the basis of expression of metastasis/invasion-related factors and p53. PMID: 15619017 Ref: A MEK inhibitor (U0126) markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice. PMID: 15743030 |
Ref: Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. PMID: 15832413 |
Ref: [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms]. PMID: 16681930 Ref: [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo]. PMID: 16784656 |
Ref: Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma. PMID: 21935919 Ref: Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. PMID: 22200632 |
Ref: Contribution of the PI3K/MMPs/Ln-5gamma2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. PMID: 23588386 |
Ref: Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5gamma2 signaling pathway. PMID: 24628713 |
Ref: Norcantharidin enhances TIMP2 antivasculogenic mimicry activity for human gallbladder cancers through downregulating MMP2 and MT1MMP. PMID: 25405519 |